Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| 1 |
Microsoft
MSFT
|
+$2.62B |
| 2 |
Apple
AAPL
|
+$2.62B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.8B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.1B |
| 5 |
Amazon
AMZN
|
+$919M |
Top Sells
| 1 |
Schlumberger
SLB
|
+$330M |
| 2 |
Marsh & McLennan
MMC
|
+$135M |
| 3 |
Booking.com
BKNG
|
+$121M |
| 4 |
Starbucks
SBUX
|
+$104M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$81.5M |
Sector Composition
| 1 | Technology | 23.84% |
| 2 | Healthcare | 15.49% |
| 3 | Consumer Discretionary | 11.17% |
| 4 | Financials | 11.02% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
iShares Core MSCI Emerging Markets ETF
IEMG
$105B
| $270K | ﹤0.01% |
6,000
-9,700
| -62% | -$437K |
|
1302
NCR Voyix
VYX
$1.79B
| $269K | ﹤0.01% |
+21,395
| New | +$269K |
|
1303
AbCellera Biologics
ABCL
$1.28B
| $268K | ﹤0.01% |
23,877
| – | – |
|
1304
Elbit Systems
ESLT
$23.1B
| $266K | ﹤0.01% |
1,372
-746
| -35% | -$145K |
|
1305
Sarepta Therapeutics
SRPT
$1.84B
| $266K | ﹤0.01% |
2,404
| – | – |
|
1306
Sapiens International
SPNS
$2.41B
| $264K | ﹤0.01% |
13,396
+37
| +0.3% | +$729 |
|
|
AYX
1307
DELISTED
Alteryx, Inc.
AYX
| $264K | ﹤0.01% |
+4,512
| New | +$264K |
|
1308
Valley National Bancorp
VLY
$6.04B
| $263K | ﹤0.01% |
22,895
| – | – |
|
|
GBT
1309
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $260K | ﹤0.01% |
3,802
| – | – |
|
1310
Ultragenyx Pharmaceutical
RARE
$3.01B
| $258K | ﹤0.01% |
+6,358
| New | +$258K |
|
|
POSH
1311
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $258K | ﹤0.01% |
14,658
-15,072
| -51% | -$265K |
|
|
UHT
1312
Universal Health Realty Income Trust
UHT
$570M
| $256K | ﹤0.01% |
6,015
-1,838
| -23% | -$78.2K |
|
1313
Grocery Outlet
GO
$1.7B
| $251K | ﹤0.01% |
7,678
+3,863
| +101% | +$126K |
|
1314
Vodafone
VOD
$28.2B
| $248K | ﹤0.01% |
21,189
| – | – |
|
|
ALTR
1315
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $247K | ﹤0.01% |
+5,099
| New | +$247K |
|
1316
Upwork
UPWK
$2.1B
| $244K | ﹤0.01% |
16,439
+13,585
| +476% | +$202K |
|
1317
CONMED
CNMD
$1.65B
| $239K | ﹤0.01% |
+2,837
| New | +$239K |
|
1318
DT Midstream
DTM
$10.9B
| $238K | ﹤0.01% |
4,331
-700
| -14% | -$38.5K |
|
1319
Lattice Semiconductor
LSCC
$9.14B
| $234K | ﹤0.01% |
4,240
+82
| +2% | +$4.53K |
|
1320
Amkor Technology
AMKR
$6.19B
| $233K | ﹤0.01% |
12,368
-1,018
| -8% | -$19.2K |
|
1321
NETSCOUT
NTCT
$1.82B
| $232K | ﹤0.01% |
+7,096
| New | +$232K |
|
1322
CTS Corp
CTS
$1.21B
| $230K | ﹤0.01% |
+5,195
| New | +$230K |
|
1323
Burford Capital
BUR
$2.75B
| $229K | ﹤0.01% |
+27,928
| New | +$229K |
|
1324
Aaon
AAON
$6.62B
| $227K | ﹤0.01% |
+6,047
| New | +$227K |
|
1325
Xerox
XRX
$467M
| $223K | ﹤0.01% |
+14,976
| New | +$223K |
|